BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17942915)

  • 21. Tumor suppression effects of bilberry extracts and enzymatically modified isoquercitrin in early preneoplastic liver cell lesions induced by piperonyl butoxide promotion in a two-stage rat hepatocarcinogenesis model.
    Hara S; Morita R; Ogawa T; Segawa R; Takimoto N; Suzuki K; Hamadate N; Hayashi SM; Odachi A; Ogiwara I; Shibusawa S; Yoshida T; Shibutani M
    Exp Toxicol Pathol; 2014 Aug; 66(5-6):225-34. PubMed ID: 24680176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shp2 deletion in hepatocytes suppresses hepatocarcinogenesis driven by oncogenic β-Catenin, PIK3CA and MET.
    Liu JJ; Li Y; Chen WS; Liang Y; Wang G; Zong M; Kaneko K; Xu R; Karin M; Feng GS
    J Hepatol; 2018 Jul; 69(1):79-88. PubMed ID: 29505847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serine protease hepsin regulates hepatocyte size and hemodynamic retention of tumor cells by hepatocyte growth factor signaling in mice.
    Hsu YC; Huang HP; Yu IS; Su KY; Lin SR; Lin WC; Wu HL; Shi GY; Tao MH; Kao CH; Wu YM; Martin PE; Lin SY; Yang PC; Lin SW
    Hepatology; 2012 Nov; 56(5):1913-23. PubMed ID: 22505209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocyte growth factor/c-met signaling is required for stem-cell-mediated liver regeneration in mice.
    Ishikawa T; Factor VM; Marquardt JU; Raggi C; Seo D; Kitade M; Conner EA; Thorgeirsson SS
    Hepatology; 2012 Apr; 55(4):1215-26. PubMed ID: 22095660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibitory effect of naringenin (citrus flavonone) on N-nitrosodiethylamine induced hepatocarcinogenesis in rats.
    Arul D; Subramanian P
    Biochem Biophys Res Commun; 2013 May; 434(2):203-9. PubMed ID: 23523793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of metallothionein predisposes mice to diethylnitrosamine-induced hepatocarcinogenesis by activating NF-kappaB target genes.
    Majumder S; Roy S; Kaffenberger T; Wang B; Costinean S; Frankel W; Bratasz A; Kuppusamy P; Hai T; Ghoshal K; Jacob ST
    Cancer Res; 2010 Dec; 70(24):10265-76. PubMed ID: 21159647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemo-preventive effect of Star anise in N-nitrosodiethylamine initiated and phenobarbital promoted hepato-carcinogenesis.
    Yadav AS; Bhatnagar D
    Chem Biol Interact; 2007 Sep; 169(3):207-14. PubMed ID: 17658503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene expression analysis on the dicyclanil-induced hepatocellular tumors in mice.
    Moto M; Okamura M; Muguruma M; Ito T; Jin M; Kashida Y; Mitsumori K
    Toxicol Pathol; 2006; 34(6):744-51. PubMed ID: 17162532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor promotion in liver of mice with a conditional Cx26 knockout.
    Marx-Stoelting P; Mahr J; Knorpp T; Schreiber S; Templin MF; Ott T; Buchmann A; Schwarz M
    Toxicol Sci; 2008 Jun; 103(2):260-7. PubMed ID: 18308698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual inhibition of Met kinase and angiogenesis to overcome HGF-induced EGFR-TKI resistance in EGFR mutant lung cancer.
    Takeuchi S; Wang W; Li Q; Yamada T; Kita K; Donev IS; Nakamura T; Matsumoto K; Shimizu E; Nishioka Y; Sone S; Nakagawa T; Uenaka T; Yano S
    Am J Pathol; 2012 Sep; 181(3):1034-43. PubMed ID: 22789825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signaling.
    Zhang XF; Tan X; Zeng G; Misse A; Singh S; Kim Y; Klaunig JE; Monga SP
    Hepatology; 2010 Sep; 52(3):954-65. PubMed ID: 20583210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA; Merlino G
    Cancer Res; 2003 Apr; 63(7):1576-82. PubMed ID: 12670907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rac1 promotes diethylnitrosamine (DEN)-induced formation of liver tumors.
    Bopp A; Wartlick F; Henninger C; Schwarz M; Kaina B; Fritz G
    Carcinogenesis; 2015 Mar; 36(3):378-89. PubMed ID: 25556150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of hepatocyte growth factor on hepatocarcinogenesis induced by peroxisome proliferators.
    Suga T; Motoki Y; Tamura H; Watanabe T
    Cell Biochem Biophys; 2000; 32 Spring():221-8. PubMed ID: 11330050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.
    Santoni-Rugiu E; Preisegger KH; Kiss A; Audolfsson T; Shiota G; Schmidt EV; Thorgeirsson SS
    Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9577-82. PubMed ID: 8790372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of c-Met disrupts gene expression program required for G2/M progression during liver regeneration in mice.
    Factor VM; Seo D; Ishikawa T; Kaposi-Novak P; Marquardt JU; Andersen JB; Conner EA; Thorgeirsson SS
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20862286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgenic mouse models in carcinogenesis: interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
    Thorgeirsson SS; Santoni-Rugiu E
    Br J Clin Pharmacol; 1996 Jul; 42(1):43-52. PubMed ID: 8807143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress.
    Gomez-Quiroz LE; Seo D; Lee YH; Kitade M; Gaiser T; Gillen M; Lee SB; Gutierrez-Ruiz MC; Conner EA; Factor VM; Thorgeirsson SS; Marquardt JU
    Toxicology; 2016 Jun; 361-362():39-48. PubMed ID: 27394961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcription coactivator PBP/MED1-deficient hepatocytes are not susceptible to diethylnitrosamine-induced hepatocarcinogenesis in the mouse.
    Matsumoto K; Huang J; Viswakarma N; Bai L; Jia Y; Zhu YT; Yang G; Borensztajn J; Rao MS; Zhu YJ; Reddy JK
    Carcinogenesis; 2010 Feb; 31(2):318-25. PubMed ID: 20007298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.